Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • MPI Ethno. Forsch.  (3)
  • Kalliope (Nachlässe)
  • 2020-2024  (3)
  • 1955-1959
  • Singapore : Springer Nature Singapore  (3)
  • Medicine
Datasource
Material
Language
Years
  • 2020-2024  (3)
  • 1955-1959
Year
Author, Corporation
  • 1
    Online Resource
    Online Resource
    Singapore : Springer Nature Singapore | Singapore : Imprint: Palgrave Macmillan
    ISBN: 9789819714711
    Language: English
    Pages: 1 Online-Ressource (VII, 155 p. 35 illus., 34 illus. in color.)
    Series Statement: Palgrave pivot
    Parallel Title: Erscheint auch als
    Parallel Title: Erscheint auch als
    Parallel Title: Erscheint auch als
    Keywords: Asia ; Medicine ; Biology ; Technological innovations. ; biotech ; pharmaceutical industry ; biopharmaceutical research ; sino-european trade ; innovation
    Abstract: Chapter 1: The Chinese healthcare and pharmaceutical market: Ignore at your own peril -- Chapter 2: China regulatory and legal reforms: Gateway to innovation and global integration -- Chapter 3: The golden age of the Chinese biopharma: Explosive growth in a thriving ecosystem -- Chapter 4: Innovation in the Chinese biopharma: From me-too to First-in-class -- Chapter 5: The art of the biopharma deal: The China angle -- Chapter 6: End if the first cycle. A drastic rest, future challenges and opportunities.
    Abstract: This book provides an insider’s overview of the emerging Chinese biopharma sector, its dynamics and trends, first bust and boom cycle, long-term perspectives, and how as a foreign company or investor to tap into this. China has gone from a country with no innovation in drug discovery, to a country which starts to out-license its biopharma technology to the rest of the world. The Chinese biopharma sector is only a decade old, but it already has become a new driver of growth and value. The book takes a closer look at what drives Chinese innovation in the biopharma sector, how to deal with this innovation, and what opportunities and challenges this provides for foreign companies. The book also takes a deep dive into its first biopharma boom and bust cycle, and what it means for the sector. It also explains what deals Chinese biopharma companies and investors are looking for, what works and what doesn’t, and how as a foreign company can tap into the world’s second largest healthcare market. Ben Wu has close to 30 years of experience in the pharmaceutical industry, holding senior executive positions in the Asia Pacific region for multinationals like J&J and Sanofi. He was active in several China originated biopharma companies, and is the founding CEO of Citrine Medicine, a venture capital backed biopharma. Originally from Belgium, Sven Agten has been living and working in China since 2004. He is a seasoned business executive working for SMEs and multinationals, with in-depth experience about business in China. He has published several books about China, all related to China business challenges, trends and opportunities.
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Singapore : Springer Nature Singapore | Singapore : Imprint: Springer
    ISBN: 9789819986354
    Language: English
    Pages: 1 Online-Ressource(XXXII, 219 p. 114 illus., 31 illus. in color.)
    Edition: 1st ed. 2023.
    Parallel Title: Erscheint auch als
    Parallel Title: Erscheint auch als
    Parallel Title: Erscheint auch als
    Keywords: Medicine ; China ; Pharmacy. ; Pharmaceutical chemistry. ; Imperialism.
    Abstract: The Beginnings of Western Influence on Chinese Medicine, 200 BCE – 1800 CE -- Trade Wars and the Emergence of Western Pharmacy -- Union Medical College and the “Cradle of Modern Medicine” -- The Rise of Western Chemists -- “Opium Cures”, Proprietary Medicine and Soda Water -- Pharmaceutical Education and Manpower Development.
    Abstract: This book represents an important contribution to the field as it is the first to provide a detailed account of the interaction between Chinese and western medicine from a pharmacy perspective over a period of two millennia with an emphasis on the modern period from 1800-1949. None of the existing historiography on the relationship between TCM and western medicine has so far explored pharmaceutical aspects in detail. This book therefore fills an important gap in the literature and is likely to become a key resource for further study. It will be of interest to a wide audience, including pharmaceutical, imperial, and business historians, and should be essential reading for pharmacy students. But it will also be of interest to a general readership curious about the history of pharmacy in China and of western influences on Chinese medicine. Stuart Anderson, BSc, MA, PhD, FRPharmS Editor-in-Chef, Pharmaceutical Historian, Emeritus Professor of Pharmacy History, London School of Hygiene & Tropical Medicine Readers of this book, to Chiu’s credit, will be exposed to the nuanced cultural, medico-scientific, and business interactions that shaped Western pharmacy in China. Chiu puts a spotlight on the various materials, techniques, and processes of drug formulation and mass manufacture – and he rightly illustrates how pharmacy was substantiated as big business and mass manufacture. In analyses that incorporate materia medica and so-called dangerous drugs, such as opium, Chiu also articulates the complicated entangled histories of the movement, circulation, and translation of both pharmacy knowledge and goods. Yet, he appropriately acknowledges and evaluates non-Western epistemologies and practices that intermingled with Western ideas to create a novel type of pharmacy and pharmaceutical industry in China. Lucas Richert, PhD Professor & George Urdang Chair in Pharmacy History, UW-Madison Executive Director, American Institute of the History of Pharmacy Patrick Chiu's book, A History of Western Pharmacy in China, effectively presents an unbiased perspective when discussing the contributions of expatriate pharmacy academics towards the development of China's pharmaceutical profession and the modern drug industry in the first half of the twentieth century. Chiu's impartial approach and well-researched content make it a recommended resource for understanding the historical development of pharmacy in China. Kazushige Morimoto Ph.D. D.Min, Education System - Qualified Pharmacist, President, The Japanese Society for the History of Pharmacy .
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    Singapore : Springer Nature Singapore | Imprint: Palgrave Macmillan
    ISBN: 9789811919503
    Language: English
    Pages: 1 Online-Ressource (XIX, 188 p. 39 illus)
    Edition: 1st ed. 2022
    Parallel Title: Printed edition
    Parallel Title: Printed edition
    DDC: 306.461
    Keywords: Social medicine ; Mental health ; Psychiatry ; Medicine
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...